Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
. 1990 Dec;62(6):1018–1022. doi: 10.1038/bjc.1990.430

Quality of life following a false positive mammogram.

I T Gram 1, E Lund 1, S E Slenker 1
PMCID: PMC1971570  PMID: 2257206

Abstract

To assess how women regard having had a false positive mammogram screening exam, and the influence that this had on their quality of life, 126 such women were interviewed. Their responses were compared to those of 152 women randomly selected among screenees with a negative exam. Eighteen months after the screening the reported prevalence of anxiety about breast cancer was 29% among women with a false positive and 13% among women with a negative screening mammogram (P = 0.001). Of 30 women biopsied, 8 (27%) had pain in the breast and 10 (33%) had reduced sexual sensitivity. A false positive mammogram was described by 7 (5%) of the women as the worst thing they ever had experienced. However, most women with a false positive result regarded this experience, in retrospect, as but one of many minor stressful experiences creating a temporary decrease in quality of life. They report the same quality of life today as women with negative screening results and 98% would attend another screening. Even so, false positive results are a matter of concern, and efforts should be made to minimise this cost whenever a screening programme is conducted.

Full text

PDF
1021

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baines C. J., To T., Wall C. Women's attitudes to screening after participation in the National Breast Screening Study. A questionnaire survey. Cancer. 1990 Apr 1;65(7):1663–1669. doi: 10.1002/1097-0142(19900401)65:7<1663::aid-cncr2820650735>3.0.co;2-a. [DOI] [PubMed] [Google Scholar]
  2. Collette H. J., Day N. E., Rombach J. J., de Waard F. Evaluation of screening for breast cancer in a non-randomised study (the DOM project) by means of a case-control study. Lancet. 1984 Jun 2;1(8388):1224–1226. doi: 10.1016/s0140-6736(84)91704-5. [DOI] [PubMed] [Google Scholar]
  3. Dean C., Roberts M. M., French K., Robinson S. Psychiatric morbidity after screening for breast cancer. J Epidemiol Community Health. 1986 Mar;40(1):71–75. doi: 10.1136/jech.40.1.71. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Devitt J. E. False alarms of breast cancer. Lancet. 1989 Nov 25;2(8674):1257–1258. doi: 10.1016/s0140-6736(89)91860-6. [DOI] [PubMed] [Google Scholar]
  5. Eddy D. M., Hasselblad V., McGivney W., Hendee W. The value of mammography screening in women under age 50 years. JAMA. 1988 Mar 11;259(10):1512–1519. [PubMed] [Google Scholar]
  6. Ellman R., Angeli N., Christians A., Moss S., Chamberlain J., Maguire P. Psychiatric morbidity associated with screening for breast cancer. Br J Cancer. 1989 Nov;60(5):781–784. doi: 10.1038/bjc.1989.359. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Gram I. T., Lund-Larsen P. G., Rosenlund A. F., Størmer J. Mammografiscreening i Tromsø. Gjennomføring og resultat av den første mammografiscreening i Norge. Tidsskr Nor Laegeforen. 1989 Apr 10;109(10):1040–1042. [PubMed] [Google Scholar]
  8. Palli D., Del Turco M. R., Buiatti E., Carli S., Ciatto S., Toscani L., Maltoni G. A case-control study of the efficacy of a non-randomized breast cancer screening program in Florence (Italy). Int J Cancer. 1986 Oct 15;38(4):501–504. doi: 10.1002/ijc.2910380408. [DOI] [PubMed] [Google Scholar]
  9. Shapiro S., Venet W., Strax P., Venet L., Roeser R. Ten- to fourteen-year effect of screening on breast cancer mortality. J Natl Cancer Inst. 1982 Aug;69(2):349–355. [PubMed] [Google Scholar]
  10. Skrabanek P. False premises and false promises of breast cancer screening. Lancet. 1985 Aug 10;2(8450):316–320. doi: 10.1016/s0140-6736(85)90362-9. [DOI] [PubMed] [Google Scholar]
  11. Skrabanek P. The debate over mass mammography in Britain. The case against. BMJ. 1988 Oct 15;297(6654):971–972. doi: 10.1136/bmj.297.6654.971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Tabar L., Fagerberg G., Duffy S. W., Day N. E. The Swedish two county trial of mammographic screening for breast cancer: recent results and calculation of benefit. J Epidemiol Community Health. 1989 Jun;43(2):107–114. doi: 10.1136/jech.43.2.107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Tabár L., Fagerberg C. J., Gad A., Baldetorp L., Holmberg L. H., Gröntoft O., Ljungquist U., Lundström B., Månson J. C., Eklund G. Reduction in mortality from breast cancer after mass screening with mammography. Randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare. Lancet. 1985 Apr 13;1(8433):829–832. doi: 10.1016/s0140-6736(85)92204-4. [DOI] [PubMed] [Google Scholar]
  14. Verbeek A. L., Hendriks J. H., Holland R., Mravunac M., Sturmans F., Day N. E. Reduction of breast cancer mortality through mass screening with modern mammography. First results of the Nijmegen project, 1975-1981. Lancet. 1984 Jun 2;1(8388):1222–1224. doi: 10.1016/s0140-6736(84)91703-3. [DOI] [PubMed] [Google Scholar]
  15. Wright C. J. Breast cancer screening: a different look at the evidence. Surgery. 1986 Oct;100(4):594–598. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES